Gradual dose titration allows the body to adjust to semaglutide, helping reduce gastrointestinal side effects as doses increase
Another practical step is to record the rash in a tracker with time, site, and recent skin products used, because patterns emerge quickly when you log data rather than rely on memory
Its strongly recommended not to reuse needles
Step 2: The Bridge Therapies As you lower the dose of Semaglutide or Tirzepatide, we often introduce non-GLP-1 therapies to support your metabolism
Compounded Injectable Tirzepatide Suggested Dose: Inject 2.5mg once weekly subcutaneously weeks 1-4, Increase dose to 5mg once weekly on weeks 5-8
It significantly lowers HbA1c levels, a key indicator of long-term blood sugar control